Precigen, Inc. (PGEN)
3.37
-0.18
(-5.07%)
USD |
NASDAQ |
Mar 05, 16:00
3.37
0.00 (0.00%)
Pre-Market: 08:52
Precigen Cash from Investing (Quarterly) : -63.39M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Amneal Pharmaceuticals, Inc. | -45.45M |
| Corcept Therapeutics, Inc. | -11.84M |
| ADMA Biologics, Inc. | -0.276M |
| Viridian Therapeutics, Inc. | -339.42M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.07M |
| Cash from Financing (Quarterly) | 93.01M |
| Free Cash Flow | -75.62M |
| Free Cash Flow Per Share (Quarterly) | -0.0959 |
| Free Cash Flow to Equity (Quarterly) | -122.50M |
| Free Cash Flow to Firm (Quarterly) | -28.56M |
| Free Cash Flow Yield | -7.54% |